| Patents for A61P 17 - Drugs for dermatological disorders (106,455) |
|---|
| 01/19/2005 | EP1498395A1 Use of a glass composition with the aim of attaining an antioxidative effect |
| 01/19/2005 | EP1498132A1 Compositions for preventing or treating pollenosis, allergic nephritis, atopic dermatitits, asthma or urticaria |
| 01/19/2005 | EP1498128A1 Medicinal compositions containing phtocrosslinkable chitosan derivative |
| 01/19/2005 | EP1498125A1 Use of compounds having ccr antagonism |
| 01/19/2005 | EP1498121A1 Use of specific cyclolignans |
| 01/19/2005 | EP1498104A1 Hair growth tonic |
| 01/19/2005 | EP1498101A1 Composition for cell proliferation |
| 01/19/2005 | EP1497401A1 Method for obtaining ozonized oils and vegetable fats and use of said products for pharmaceutical and cosmetic purposes |
| 01/19/2005 | EP1497315A2 Nucleic acid-associated proteins |
| 01/19/2005 | EP1497306A1 Alternatively spliced nucleic acid molecules |
| 01/19/2005 | EP1497296A1 1,4 DIAZOCINO 7,8,1-hi INDOLE DERIVATIVES AS ANTIPSYCHOTIC AND ANTIOBESITY AGENTS |
| 01/19/2005 | EP1497294A1 1,2,3,4,7,8-HEXAHYDRO-6 i H /i - 1,4 DIAZEPINO 6,7 ,1- i 1J /i QUINOLINE DERIVATIVES AS ANTIPSYCHOTIC AND ANTI OBESITY AGENTS |
| 01/19/2005 | EP1497292A1 Azaindolylpiperidine derivatives as antihistaminic and antiallergic agents |
| 01/19/2005 | EP1497273A2 Hydroxamic acid derivatives |
| 01/19/2005 | EP1497268A2 Nitric oxide donors, compositions and methods of use |
| 01/19/2005 | EP1497261A1 Phenethanolamine derivatives |
| 01/19/2005 | EP1497256A1 Substituted 1,5-diaminopentan-3-ol compounds |
| 01/19/2005 | EP1497019A1 Pyrrolo-triazine aniline compounds useful as kinase inhibitors |
| 01/19/2005 | EP1496951A1 Wound dressings comprising hydrated hydrogels and enzymes |
| 01/19/2005 | EP1496941A1 Glycodendrimers having biological activity |
| 01/19/2005 | EP1496930A2 G-type peptides to ameliorate atherosclerosis |
| 01/19/2005 | EP1496917A1 Combination of a beta-2 adrenoceptor agonists and an aminosugars and their use for the treatment immunomodulatory disorders |
| 01/19/2005 | EP1496914A1 (20S)-1a-HYDROXY-2a-METHYL AND 2&bgr;-METHYL-19-NOR-VITAM IN D sb 3 /sb AND THEIR USES |
| 01/19/2005 | EP1496910A1 Kinase inhibitors |
| 01/19/2005 | EP1496907A2 Tyrosine kinase inhibitors |
| 01/19/2005 | EP1496905A2 Modulators of hedgehog signaling pathways, compositions and uses related thereto |
| 01/19/2005 | EP1496904A1 Pharmaceutical containing n, n'-disubstituted piperazine compounds |
| 01/19/2005 | EP1496899A1 Use of materials having zinc ionophoric behavior |
| 01/19/2005 | EP1496898A2 Tyrosine kinase inhibitors |
| 01/19/2005 | EP1496895A1 Use of cyclopamine in the treatment of psoriasis and other skin disorders |
| 01/19/2005 | EP1496894A1 Angiogenesis inhibitors |
| 01/19/2005 | EP1496892A2 1h-benzo(f)indazol-5-yl derivatives as selective glucocorticoid receptor modulators |
| 01/19/2005 | EP1496891A2 Methods for modulating phototoxicity |
| 01/19/2005 | EP1496890A1 Substituted beta-aminoalcohols used as medicaments |
| 01/19/2005 | EP1496889A1 Stabilized ascorbic acid derivatives |
| 01/19/2005 | EP1496887A1 Personal care compositions comprising a zinc containing material in an aqueous surfactant composition |
| 01/19/2005 | EP1496881A2 Chromium compositions and methods for using the same for inhibiting drug-induced insulin resistance |
| 01/19/2005 | EP1496878A1 Methods for identification of modulators of angiogenesis, compounds discovered thereby, and methods of treatment using the compounds |
| 01/19/2005 | EP1496875A1 Use of a mare's milk concentrate dried on a highly-dispersed, biologically inert matrix |
| 01/19/2005 | EP1496865A1 Method for the production of crystals, crystals obtained by said method, and use thereof in pharmaceutical formulations |
| 01/19/2005 | EP1496863A2 Preparation and use of a stable formulation of allosteric effector compounds |
| 01/19/2005 | EP1496838A2 Substituted amides |
| 01/19/2005 | EP1392366A4 Nuclear receptor-mediated introduction of a pna into cell nuclei |
| 01/19/2005 | EP1377574B1 6-phenylbenzonaphthyridines |
| 01/19/2005 | EP1208104B1 Tricyclic inhibitors of poly(adp-ribose) polymerases |
| 01/19/2005 | EP0545946B1 Growth-promoting agent |
| 01/19/2005 | CN1568331A Biological products |
| 01/19/2005 | CN1568321A Novel substituted 4-phenyl-4-ú¿1h-imidazol-2-ylú®-piperidine derivatives and their use as selective non-peptide delta opioid agonists |
| 01/19/2005 | CN1568320A 异羟肟酸衍生物 Hydroxamic acid derivatives |
| 01/19/2005 | CN1568310A Heterocyclic inhibitors of glycogen synthase kinase GSK-3 |
| 01/19/2005 | CN1568207A 2-amino-6-(2, 4, 5-substituted-phenyl)-pyridines |
| 01/19/2005 | CN1568177A Anti-microbial composition comprising a metal ion chelating agent |
| 01/19/2005 | CN1565627A Hemoglobin alpha chain peptide fragments useful for inhibiting stem cell proliferation |
| 01/19/2005 | CN1565624A Carbowaxing recombiant human growth hormone medicine and its preparation process |
| 01/19/2005 | CN1565614A Externally applied medicinal composition for resisting inflammation and repressing and killing bacteria and preparing method |
| 01/19/2005 | CN1565603A Preparing method of several Chinese herbal prescription |
| 01/19/2005 | CN1565597A Chinese herbal medicine for treating burns and scalds and its preparing process |
| 01/19/2005 | CN1565590A Skin injury treating Chinese traditional medicine |
| 01/19/2005 | CN1565586A Scar eliminating medicine |
| 01/19/2005 | CN1565581A Immune function regulating antibiotic and anti-inflammatory drug with broad spectrum |
| 01/19/2005 | CN1565575A Medicinal liquor for preventing and treating skin disease of hands and feet and its preparing process |
| 01/19/2005 | CN1565550A Chinese traditional medicine for treating gynecopathy and dermatoses and preparation thereof |
| 01/19/2005 | CN1565547A Ointment for treating burns and scalds and its preparation |
| 01/19/2005 | CN1565534A Chinese traditional medicinal combination for treating putrescence of malignant disease |
| 01/19/2005 | CN1565533A Prescription of body surface shielding film and its preparing method |
| 01/19/2005 | CN1565517A Preparing method of nanometer level high purity freeze dried powder of aloe and its preparation |
| 01/19/2005 | CN1565505A Burn treating medicine |
| 01/19/2005 | CN1565499A Chinese traditional medicine for treating traumatic injury |
| 01/19/2005 | CN1565498A Burn treating Chinese traditional medicine |
| 01/19/2005 | CN1565489A Wound repairing and burns treating cream |
| 01/19/2005 | CN1565481A Prescription of a beautifying honey product |
| 01/19/2005 | CN1565462A Itch relieving detumescent medicine |
| 01/19/2005 | CN1565460A Acne therapeutic chemical tincture and its preparation method |
| 01/19/2005 | CN1565459A Dermatopathy therapeutic medicine compositions and its preparation method |
| 01/19/2005 | CN1565453A 6-amino-ª‡(R)-hydroxyl-9H-purin-9-ethyl butyrate immunological suppression effect |
| 01/19/2005 | CN1565436A Retinoic acid release control nanomicrosphere and its preparation method |
| 01/19/2005 | CN1565421A A set of externally used products capable of killing multiple pathogenic microorganism |
| 01/19/2005 | CN1565415A Biological preparation enriched with activation regeneration factor and its uses |
| 01/19/2005 | CN1185233C Aryl and heteroaryl diazabicycloalkanes, their preparation and use |
| 01/19/2005 | CN1185232C Inhibitors of alpha L beta 2 mediated cell adhesion |
| 01/19/2005 | CN1185229C 3-indolyl-4-phenyl-1H-pyrrole-2, 5-dione derivatives as inhibitors of glycogen synthase kinase-3beta |
| 01/19/2005 | CN1185215C Substituted glutarimides and use as IL-12 production inhibitors thereof |
| 01/19/2005 | CN1185211C Benzamide derivatives for the treatment of diseases resulted from cytokines |
| 01/19/2005 | CN1184998C Face-toning dryness-moistening capsule |
| 01/19/2005 | CN1184993C Medicine for treating psoriasis |
| 01/19/2005 | CN1184984C Chinese-medicinal ointment for treating burn and scald and its preparing process |
| 01/19/2005 | CN1184983C Chinese medicine compositions for regenerating hair |
| 01/18/2005 | US6844466 Treating or preventing emphysema, cancer and dermatological disorders |
| 01/18/2005 | US6844457 Antiproliferative agents; anticancer agents; antiinflammatory agents |
| 01/18/2005 | US6844435 Heterocyclic compounds useful as inhibitors of tyrosine kinases |
| 01/18/2005 | US6844365 Using diacerein or a pharmaceutically acceptable derivative or rhein for the manufacture of a pharmaceutical formulation for the treatment of psoriasis and diseases associated therewith |
| 01/18/2005 | US6844349 Salt forms of E-2-methoxy-N-(3-{4-[3 methyl-4-(6-methyl-pyridin-3-yloxy)-phenylamino]-quinazolin-6-yl}-allyl)-acetamide and method of production |
| 01/18/2005 | US6844341 Cell cycle kinase inhibitors; such as 2-(4-(N-(2-methoxy-ethyl)-sulphamoyl)anilino)-4-(imidazo(1,2b)pyridazin-3 -yl)-pyrimidine |
| 01/18/2005 | US6844336 4-fluoroalkyl-2h-benzopyrans with anti-estogenic activity |
| 01/18/2005 | US6844335 2-amino-3-(alkyl)-pyrimidone derivatives as GSK3.β.inhibitors |
| 01/18/2005 | US6844332 (20S)-1α-hydroxy-2α-methyl and 2β-methyl-19-nor-vitamin D3 and their uses |
| 01/18/2005 | US6844331 (20S)-1α-hydroxy-2α-methyl and 2β-methyl-19-nor-vitamin D3 and their uses |
| 01/18/2005 | US6844330 (20S)-1α-hydroxy-2α-methyl and 2β-methyl-19-NOR-vitamin D3 and their uses |
| 01/18/2005 | US6844328 Antiproliferative activity; low systemic toxicity; psoriasis, tumors, rheumatoid arthritis, intestinal inflammation |
| 01/18/2005 | US6844180 Nucleotide sequences for use in the treatment of viral diseases, hypertension and coagulation defects |